Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Sales | 569 | 2,474 | 3,761 | 3,190 | 4,211 |
| Gross Profit | 569 | 2,474 | 3,761 | 3,190 | 4,211 |
| Operating Expenses | 7,197 | 7,586 | 9,453 | 4,157 | 6,831 |
| Operating Income | -6,628 | -5,112 | -5,692 | -968 | -2,621 |
| Other Income | 17,758 | -633 | -7,801 | -6,318 | 92 |
| Pre-tax Income | 11,130 | -5,745 | -13,493 | -7,286 | -2,529 |
| Net Income Continuous | 11,130 | -5,745 | -13,493 | -7,286 | -2,529 |
| Minority Interests | -238 | -246 | -134 | -82 | -89 |
| Net Income | $11,368 | $-5,499 | $-13,359 | $-7,203 | $-2,440 |
| EPS Basic Total Ops | 7.60 | -3.80 | -10.20 | -5.40 | -1.80 |
| EPS Basic Continuous Ops | 7.41 | -3.95 | -10.22 | -5.40 | -1.89 |
| EPS Diluted Total Ops | 6.00 | -3.80 | -10.20 | -5.40 | -1.80 |
| EPS Diluted Continuous Ops | 5.92 | -3.95 | -10.22 | -5.40 | -1.89 |
| EBITDA(a) | $-6,515 | $-5,002 | $-5,586 | $-866 | $-2,522 |